|
Video: What is a Stock Split?
|
|
Novogen is a global oncology biotechnology company, focused on developing cancer treatments. Co. has two main drug technology platforms: super-benzopyran and anti-tropomyosins (ATM). Within those platforms, Co. has three drug candidates under development: Cantrixil (TRX-E-002-1), for women with later-stage ovarian cancer; Anisina (ATM-3507), which is designed to enhance chemotherapy agents such as taxanes and vinca alkaloids, which are used across a range of cancer treatments including lung, prostate, colon, gastric, prostrate, pancreatic and breast cancer, as well as many childhood cancers; and Trilexium (TRX-E-009-1), for treatment of renal cancer and several childhood cancers. According to our NVGN split history records, NVGN has had 2 splits. | |
|
NVGN (NVGN) has 2 splits in our NVGN split history database. The first split for NVGN took place on January 28, 2013. This was a 3038 for 1000 split, meaning for each 1000 shares of NVGN owned pre-split, the shareholder now owned 3038 shares. For example, a 1000 share position pre-split, became a 3038 share position following the split. NVGN's second split took place on January 03, 2012. This was a 1 for 5 reverse split, meaning for each 5 shares of NVGN owned pre-split, the shareholder now owned 1 share. For example, a 3038 share position pre-split, became a 607.6 share position following the split.
When a company such as NVGN splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as NVGN conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the NVGN split history from start to finish, an original position size of 1000 shares would have turned into 607.6 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into NVGN shares, starting with a $10,000 purchase of NVGN, presented on a split-history-adjusted basis factoring in the complete NVGN split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
11/22/2017 |
|
Start price/share: |
$3.94 |
|
End price/share: |
$3.17 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-19.54% |
|
Average Annual Total Return: |
-5.91% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$8,045.51 |
|
Years: |
3.57 |
|
|
|
Date |
Ratio |
01/28/2013 | 3038 for 1000 | 01/03/2012 | 1 for 5 |
|
|